MOG and myeloid sarcoma: Native MOG antibodies were present in 47% of children with a demyelinating event (ADEM or clinically isolated syndrome), 6.9% of children with other neurological diseases, and absent in healthy controls as well as adults with MS and children with type I diabetes mellitus.